Anthony Lembo, MD, FACG

Beth Israel Deaconess Medical Center and Harvard Medical School

Poster(s):

• B0274 - IgG-based Elimination Diets for Patients with IBS: Results From a Prospective, Multi-Center, Double-Blind, Placebo-Controlled Trial
  Monday, October 24, 2022

  10:00 AM – 12:00 PM ET

• C0268 - Efficacy of Tenapanor in Improving IBS-C Abdominal Symptoms: A Post Hoc Analysis of Multi-Item Abdominal Score From the 26-Week Phase 3 T3MPO-2 Study
  Monday, October 24, 2022

  3:00 PM – 5:00 PM ET